Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | -10.71 | 2.63 | 53.50 | 7.03 |
Depreciation/ Depletion | 8.37 | 9.35 | 5.88 | 1.32 |
Non- Cash Items | 11.52 | 11.34 | 10.92 | 6.15 |
Changesin Working Capital | -18.68 | 3.06 | -45.58 | -5.28 |
Cashfrom Operating Activities | -9.49 | 26.38 | 24.72 | 9.14 |
Capital Expenditures | -5.57 | -10.44 | -41.34 | -4.24 |
Other Investing Cash Flow Items Total | 25.46 | 1.12 | -3.07 | -3.45 |
Cashfrom Investing Activities | 19.89 | -9.33 | -44.41 | -7.70 |
Financing Cash Flow Items | -10.64 | -11.75 | -7.96 | -2.97 |
Issuance( Retirement)of Stock Net | 0.00 | 2.00 | - | 0.00 |
Issuance( Retirement)of Debt Net | 0.24 | -7.32 | 28.92 | 1.78 |
Cashfrom Financing Activities | -10.40 | -17.07 | 19.93 | -1.19 |
Net Changein Cash | -0.01 | -0.02 | 0.23 | 0.26 |
Cash Interest Paid | 10.64 | 11.75 | 7.96 | 2.97 |
Cash Taxes Paid | 13.41 | 3.46 | 0.53 | 3.18 |
Total Cash Dividends Paid | - | 0.00 | -1.04 | - |
Deferred Taxes | - | - | - | -0.69 |
ANG Lifesciences India Dividend ANG Lifesciences India Bonus ANG Lifesciences India News ANG Lifesciences India AGM ANG Lifesciences India Rights ANG Lifesciences India Splits ANG Lifesciences India Board Meetings ANG Lifesciences India Key Metrics ANG Lifesciences India Shareholdings ANG Lifesciences India Profit Loss ANG Lifesciences India Balance Sheet ANG Lifesciences India Q1 Results ANG Lifesciences India Q2 Results ANG Lifesciences India Q3 Results ANG Lifesciences India Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks